|
47
|
226
|
5yjmA |
Human chymase in complex with 7-oxo-3-(phenoxyimino)-1,4-diazepane derivative |
|
47
|
236
|
5xrfA |
Crystal structure of da-36, a thrombin-like enzyme from deinagkistrodon acutus |
|
58
|
223
|
5xwlA |
Crystal structure of porcine pancreatic trypsin with tripeptide inhibitor, tre, at ph 10 |
|
54
|
248
|
5ubmA |
Crystal structure of human c1s in complex with inhibitor gigastasin |
|
50
|
238
|
5wb6A |
Factor xia in complex with the inhibitor methyl [(11s)-11-({(2e)-3-[5-chloro-2-(1h-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-6-fluoro-2-oxo-1,3,4,10,11,13-hexahydro-2h-5,9:15,12-di(azeno)-1,13-benzodiazacycloheptadecin-18-yl]carbamate |
|
51
|
246
|
5xg4U |
Crystal structure of upa in complex with quercetin |
|
56
|
247
|
5wxpU |
Crystal structure of upa in complex with upain-2-3-w3a |
|
62
|
223
|
5f6mA |
Isotropic trypsin model for comparison of diffuse scattering |
|
93
|
369
|
5ce1A |
Crystal structure of serine protease hepsin in complex with inhibitor |
|
50
|
224
|
5fahA |
Kallikrein-7 in complex with compound1 |
|
57
|
224
|
5c67A |
Human mesotrypsin in complex with amyloid precursor protein inhibitor variant appi-m17g/i18f/f34v |
|
70
|
248
|
5c2zA |
Molecular insights into the specificity of exfoliative toxins from staphylococcus aureus |
|
49
|
251
|
5brrE |
Michaelis complex of tpa-s195a:pai-1 |
|
64
|
335
|
5b6lA |
Structure of deg protease hhoa from synechocystis sp. pcc 6803 |
|
42
|
218
|
5abwA |
Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases |
|
42
|
218
|
5a8zA |
Crystal structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor |
|
43
|
218
|
5a8yA |
Crystal structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor |
|
41
|
218
|
5a8xA |
Crystal structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor |
|
56
|
257
|
5af9H |
Thrombin in complex with 4-methoxy-n-(2-pyridinyl)benzamide |
|
44
|
218
|
5a09A |
Crystal structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor |
|
42
|
218
|
5a0cA |
Crystal structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor |
|
58
|
257
|
5a2mH |
Thrombin inhibitor |
|
43
|
218
|
5a0bA |
Crystal structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor |
|
42
|
218
|
5a0aE |
Crystal structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor |
|
59
|
247
|
4zkoU |
The crystal structure of upain-1-w3a in complex with upa at ph7.4 |
|
57
|
247
|
4zhlU |
The crystal structure of mupain-1-ig in complex with murinised human upa at ph7.4 |
|
60
|
249
|
4zmaH |
Crystal structure of a fviia-trypsin chimera (st) in complex with soluble tissue factor |
|
63
|
249
|
4z6aH |
Crystal structure of a fviia-trypsin chimera (yt) in complex with soluble tissue factor |
|
60
|
240
|
4ym9A |
Crystal structure of porcine pancreatic elastase (ppe) in complex with the novel inhibitor jm102 |
|
61
|
254
|
4yt7H |
Factor viia in complex with the inhibitor 2-(2-{(r)-[(4-carbamimidoylphenyl)amino][5-ethoxy-2-fluoro-3-(propan-2-yloxy)phenyl]methyl}-1h-imidazol-4-yl)benzamide |
|
68
|
314
|
4f4oC |
Structure of the haptoglobin-haemoglobin complex |
|
197
|
789
|
4durA |
The x-ray crystal structure of full-length type ii human plasminogen |
|
54
|
258
|
4dy7B |
Crystal structures of protease nexin-1 in complex with s195a thrombin |
|
57
|
258
|
4dt7B |
Crystal structure of thrombin bound to the activation domain qedqvdprlidgkmtrrgds of protein c |
|
59
|
240
|
4estE |
Crystal structure of the covalent complex formed by a peptidyl alpha,alpha-difluoro-beta-keto amide with porcine pancreatic elastase at 1.78-angstroms resolution |
|
64
|
259
|
4e05H |
Anophelin from the malaria vector inhibits thrombin through a novel reverse-binding mechanism |
|
56
|
246
|
4dvaU |
The crystal structure of human urokinase-type plasminogen activator catalytic domain |
|
60
|
259
|
4e06H |
Anophelin from the malaria vector inhibits thrombin through a novel reverse-binding mechanism |
|
57
|
257
|
4e7rG |
Thrombin in complex with 3-amidinophenylalanine inhibitor |
|
38
|
241
|
4dw2U |
The crystal structure of upa in complex with the fab fragment of mab-112 |
|
52
|
223
|
4doqA |
Crystal structure of the complex of porcine pancreatic trypsin with 1/2slpi |
|
124
|
789
|
4duuA |
The x-ray crystal structure of full-length type i human plasminogen |
|
54
|
238
|
4cr5A |
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design |
|
44
|
251
|
4djzB |
Catalytic fragment of masp-1 in complex with its specific inhibitor developed by directed evolution on sgci scaffold |
|
54
|
238
|
4craA |
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design |
|
52
|
222
|
4d8nA |
Human kallikrein 6 inhibitors with a para-amidobenzylanmine p1 group carry a high binding efficiency |
|
58
|
228
|
4d9qA |
Inhibiting alternative pathway complement activation by targeting the exosite on factor d |
|
51
|
238
|
4crbA |
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design |
|
59
|
228
|
4d9rA |
Inhibiting alternative pathway complement activation by targeting the exosite on factor d |
|
55
|
237
|
4crcA |
Creating novel f1 inhibitors through fragment based lead generation and structure aided drug design |
